🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase Ib/II trial aims to evaluate the safety and preliminary efficacy...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-12
Trial ID
NCT07785856
Treatments Being Tested
Single institution study to assess the safety of concurrent Azeliragon with...
Status
Active Not Recruiting
Location
NYU Langone Health
Start Date
2025-02-18
Trial ID
NCT06724926
Treatments Being Tested
This is an open label study to determine the safety and preliminary evidenc...
Status
Unknown
Location
Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute
Start Date
2023-06-01
Trial ID
NCT05766748
Treatments Being Tested
This is a study to evaluate the efficacy and safety of azeliragon in patien...
Status
Terminated
Location
Multiple Locations
Start Date
2015-04
Trial ID
NCT02080364
Treatments Being Tested
This is an open-label extension study in patients with mild Alzheimer's dis...
Status
Terminated
Location
Multiple Locations
Start Date
2016-12
Trial ID
NCT02916056
Treatments Being Tested
This is a study to evaluate the efficacy and safety of azeliragon in patien...
Status
Terminated
Location
Tucson Neuroscience Research
Start Date
2019-06-27
Trial ID
NCT03980730
Treatments Being Tested
This is a pilot study to evaluate the effects of azeliragon to decrease car...
Status
Recruiting
Location
Georgetown Lombardi Comprehensive Cancer Center
Start Date
2023-06-06
Trial ID
NCT05256745
Treatments Being Tested